Chemotherapy regimens
ALL
AML
Each patient in this study was treated with a reasonable chemotherapy regimen based on their own conditions. Drugs commonly used to treat AML include idarubicin, cytarabine, high-spinel, etoposide, fludarabine, cladribine, azacitidine, decitabine, arsenic acid, venetoclax, and other novel chemotherapy drugs. Drugs commonly used to treat ALL include cyclophosphamide, vincristine, pirarubicin, methotrexate, cytarabine, dexamethasone, pegaspargase, etoposide, tyrosine kinase inhibitors imatinib, dasatinib, and other novel chemotherapy drugs. The choice of chemotherapy drugs was standardized for patients within each group, implying that these patients were not treated significantly differently.